The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Roche; Sotio
Olaparib monotherapy versus (vs) chemotherapy for germline BRCA-mutated (gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase III SOLO3 trial.
 
Richard T. Penson
Honoraria - Abbvie; Amgen; AstraZeneca; Baxalta; Clovis Oncology; Eisai; Genentech; Merck; Mersana; Sutter Medical Group; Tesaro; Vascular Biogenics
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Baxalta; Care4ward; Clovis Oncology; Eisai; Genentech; Merck; Mersana; Sutter Medical Group; Tesaro; Vascular Biogenics
Research Funding - Array BioPharma (Inst); AstraZeneca (Inst); Cerulean Pharma (Inst); Eisai (Inst); Genentech (Inst); Regeneron (Inst); Sanofi (Inst); Tesaro (Inst); Vascular Biogenics (Inst)
Patents, Royalties, Other Intellectual Property - Blackwell Publishing; BMJ; UpToDate
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; Genentech; Tesaro; Vascular Biogenics
Other Relationship - Abbvie
 
Ricardo Villalobos Valencia
Consulting or Advisory Role - Amgen; Lilly; Novartis; Pfizer; Roche
Speakers' Bureau - Amgen; Pfizer; Roche
Expert Testimony - Amgen; Lilly; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Amgen; Pfizer; Roche
 
David Cibula
No Relationships to Disclose
 
Nicoletta Colombo
Honoraria - AstraZeneca; PharmaMar; Roche/Genentech; Tesaro
Consulting or Advisory Role - AstraZeneca; BioCad; Clovis Oncology; MSD Oncology; Pfizer; PharmaMar; Roche/Genentech; Takeda; Tesaro
 
Charles A. Leath
Honoraria - Mateon Therapeutics
Consulting or Advisory Role - Celsion; Unleash Immuno Oncolytics
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Celsion (Inst); Mateon Therapeutics (Inst); Merck (Inst); Novartis (Inst); Plexxikon (Inst); Roche/Genentech (Inst); Syros Pharmaceuticals (Inst); Tesaro (Inst)
 
Mariusz Bidziński
No Relationships to Disclose
 
Jae-Weon Kim
No Relationships to Disclose
 
Joo-Hyun Nam
No Relationships to Disclose
 
Radoslaw Madry
No Relationships to Disclose
 
Carlos Hernández Hernández
No Relationships to Disclose
 
Paulo Alexandre Ribeiro Mora
No Relationships to Disclose
 
Sang Young Ryu
No Relationships to Disclose
 
Tsveta Milenkova
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Elizabeth S. Lowe
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Laura Barker
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Giovanni Scambia
No Relationships to Disclose